- Home
- ZGM vs INMB Comparison
ZGM vs INMB Comparison
Compare ZGM & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZGM
- INMB
- Stock Information
- Founded
- ZGM 2019
- INMB 2015
- Country
- ZGM Macau
- INMB United States
- Employees
- ZGM N/A
- INMB N/A
- Industry
- ZGM Professional Services
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- ZGM Consumer Discretionary
- INMB Health Care
- Exchange
- ZGM Nasdaq
- INMB Nasdaq
- Market Cap
- ZGM 43.6M
- INMB 49.2M
- IPO Year
- ZGM 2025
- INMB 2019
- Fundamental
- Price
- ZGM $3.27
- INMB $1.87
- Analyst Decision
- ZGM
- INMB Hold
- Analyst Count
- ZGM 0
- INMB 3
- Target Price
- ZGM N/A
- INMB $4.30
- AVG Volume (30 Days)
- ZGM 190.1K
- INMB 349.2K
- Earning Date
- ZGM 01-06-2026
- INMB 10-30-2025
- Dividend Yield
- ZGM N/A
- INMB N/A
- EPS Growth
- ZGM 401.52
- INMB N/A
- EPS
- ZGM 0.17
- INMB N/A
- Revenue
- ZGM $3,620,780.00
- INMB $50,000.00
- Revenue This Year
- ZGM N/A
- INMB $264.29
- Revenue Next Year
- ZGM N/A
- INMB $9,819.61
- P/E Ratio
- ZGM $18.66
- INMB N/A
- Revenue Growth
- ZGM 211.78
- INMB N/A
- 52 Week Low
- ZGM $2.00
- INMB $1.71
- 52 Week High
- ZGM $4.51
- INMB $11.64
- Technical
- Relative Strength Index (RSI)
- ZGM N/A
- INMB 45.15
- Support Level
- ZGM N/A
- INMB $1.79
- Resistance Level
- ZGM N/A
- INMB $1.95
- Average True Range (ATR)
- ZGM 0.00
- INMB 0.10
- MACD
- ZGM 0.00
- INMB 0.01
- Stochastic Oscillator
- ZGM 0.00
- INMB 46.00
About ZGM Zenta Group Company Limited Ordinary Shares
Zenta Group Co Ltd is engaged in the provision of industrial park consultation services, business investment consultation services to clients through LIC, and sales of fintech products and services through LFT. Its industrial park consultation services are focused on the pre-development stage. Its business investment consultation services, offered through LIC, mainly focus on assisting clients to acquire stakes in specific investments, and it's normally in the form of equity ownership.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.